Eskalith, Lithane, Lithium Carbonate, Lithobid, Lithonate, Lithotabs (lithium carbonate) is a small molecule pharmaceutical. Lithium carbonate was first approved as Eskalith on 1982-01-01. It is used to treat bipolar disorder, conduct disorder, depressive disorder, and post-traumatic stress disorders in the USA. The pharmaceutical is active against inositol monophosphatase 1. In addition, it is known to target glycogen synthase kinase-3 beta.
|Trade Name||Eskalith, Lithane, Lithium Carbonate, Lithobid, Lithonate, Lithotabs|
|Common Name||Lithium carbonate|
|Indication||bipolar disorder, conduct disorder, depressive disorder, post-traumatic stress disorders|